EvlaBio

Zürich, Switzerland

EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.

$24.6M raised

Jul 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has EvlaBio raised?

EvlaBio has raised $24.6M in total funding. The most recent round was Seed. The last funding was announced in July 2025.

Who are EvlaBio's investors?

EvlaBio's investors include HTGF (High-Tech Gruenderfonds), Kurma Partners, Boehringer Ingelheim Venture Fund, AdBio partners, NRW.Venture.

Where is EvlaBio headquartered?

EvlaBio is headquartered in Zürich, Switzerland.

What does EvlaBio do?

EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs.

What stage is EvlaBio at?

EvlaBio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 7, 2025.

MLA

"EvlaBio — Funding & Investors." VCBacked, July 7, 2025, https://www.vcbacked.co/company/evlabio. Accessed July 1, 2026.

APA

VCBacked. (2025). EvlaBio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/evlabio

Wikipedia (cite web)

{{cite web |title=EvlaBio — Funding & Investors |url=https://www.vcbacked.co/company/evlabio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 7, 2025.